ALD-151, umbilical cord blood cells for hematologic and immunodefeciency diseases
ALD-151 are umbilical cord blood (UCB) cells that are selected based on their high levels of aldehyde dehydrogenase (ALDH) expression. These cells are used in order to improve engraftment of transplants introduced for treatment of hematological malignancies, congenital marrow failure and congenital immunodeficiency syndromes.
Read More
Product Information for
ALD-151, umbilical cord blood cells for hematologic and immunodefeciency diseases
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access